Calcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patients

Cardiovascular Research

Volumn 41, Issue 1, 1999, Pages 299-306

  Perticone, Francesco ^a   Ceravolo, Roberto ^a   Maio, Raffaele ^a   Ventura, Giorgio ^a   Iacopino, Saverio ^a   Cuda, Giovanni ^a   Mastroroberto, Pasquale ^a   Chello, Massimo ^a   Mattioli, Pier L ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Acetylcholine; Antihypertensive therapy; Calcium channel blocker; Endothelium; Hypertension; Isradipine

Indexed keywords

ACETYLCHOLINE; CALCIUM ANTAGONIST; ISRADIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARM BLOOD FLOW; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM ANTAGONISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; VASODILATATION;

ACETYLCHOLINE; ADULT; ANALYSIS OF VARIANCE; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOREARM; HUMANS; HYPERTENSION; ISRADIPINE; MALE; MIDDLE AGED; NITROPRUSSIDE; REGIONAL BLOOD FLOW; TIME FACTORS; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0032951819     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00224-7     Document Type: Article

References (51)

1. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
2. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetycholine. Nature 1980;288:373-376.
3. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
4. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possess pharmacologic and chemical properties identical to those of the nitric oxide radicals. Circ Res 1987;61:866-879.
5. Myers PR, Minor Jr. RL, Guerra Sr. R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble s-nitrosocysteine than nitric oxide. Nature 1990;345:161-163.
6. Lüsher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton: CRC Press, 1990.
7. Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS. Modulation of vascular smooth muscle contraction by the endothelium. Ann Rev Physiol 1986;48:307-320.
8. Smith RP, Kruszyna H. Nitroprusside produces cyanide poisoning via reaction with hemoglobin. J Pharmacol Exp Ther 1974;191:557-563.
9. Panza JA, Quyyumi AA, Brush Jr. JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-27.
10. Linder L, Kiowski W, Bühler F, Lüscher T. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990;81:1762-1767.
11. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-497.
12. Lusher TF, Cooke JP, Houston DS, Neves RJ, Vanhoutte PM. Endothelium-dependent relaxations in human arteries. Mayo Clin Proc 1987;62:601-606.
13. Thom S, Hughes A, Martin G, Sever PS. Endothelium-dependent relaxation in isolated human arteries and veins. Clin Sci 1987;73:547-552.
14. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2:997-1000.
15. Förstermann U, Mügge A, Alheid U, Haverich A, Frölich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988;62:185-190.
16. Dohi Y, Thiel MA, Buhler FR, Luscher TF. Activation of endothelial L-arginine pathway in resistence arteries. Effect of age and hypertension. Hypertension 1990;15:170-179.
17. Taddei S, Virdis A, Mattei P. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation 1995;91:1981-1987.
18. Creager MA, Cooke JP, Mendelson ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-234.
19. Zeither AM, Drexler H, Saubier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercolesterolaemia, and hypertension. J Clin Invest 1993;92:652-662.
20. Johnstone MT, Creager SJ, Scales KM, et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-2516.
21. Zeiher AM, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilation function. Circulation 1995;92:1094-1100.
22. Cockroft JR, Chowiencczyk PJ, Benjiamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994;330:1036-1040.
23. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993;21:1145-1151.
24. Creager MA, Roddy M-A. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994;24:499-505.
25. Kiowski W, Linder L, Nuesch R, Martina B. Effect of cilazapril on vascular structure and function in essential hypertension. Hypertension 1996;27(part 1):371-376.
26. Hirooka Y, Imaizumi T, Masaki H, et al. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992;20:175-180.
27. Griebenow R, Kaufmann W, Kramer L, et al. Isradipine: a new calcium antagonist with strong vasodilatatory but negligible cardiodepressive effects. J Cardiovasc Pharmacol 1990;15(Suppl 1):S84-S86.
28. Lacourciere Y, Poirier L, Dion D, Provencher P. Antihypertensive effect of isradipine admistered once or twice daily on ambulatory blood pressure. Am J Cardiol 1990;65:467-472.
29. Perticone F, Pugliese F, Marcantonio AM, et al. Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring. Clin Cardiol 1995;18:401-407.
30. Habib JB, Bossaller C, Wells S, et al. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Cire Res 1986;58:305-309.
31. White WB, Pickering TG, Morganroth J, et al. A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 1991;4:890-896.
32. Greenfield ADM, Whitney RJ, Mowbray JF. Methods for the investigation of peripheral blood flow. Br Med Bull 1963;19:101-109.
33. Hokanson DE, Sumner DS, Strandness Jr. DE. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 1975;22:25-29.
34. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure: the Framingham Study. N Engl J Med 1972;287:781-787.
35. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
36. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-838.
37. Lüscher TF, Vanhoutte PM, Raij L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension 1987;2 (Suppl III):193-197.
38. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazina on endothelial function in hypertensive rats. Hypertension 1990;16:532-540.
39. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993;87:1475-1481.
40. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993;21:929-933.
41. Laurent S, Lacolle P, Brunel P, et al. Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol 1990;258:H1004-H1111.
42. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol 1994;23:1610-1616.
43. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995;91:1732-1738.
44. Klaus W., Berkels R., Dhein S. et al. Endothelium-dependent actions of dihydropiridine calcium antagonist. In: Born, GVR, Schwartz, CJ, editors. Vascular endothelium: physiology, pathology, and therapeutic opportunities. New York: Schattauer, 1997.
45. Fleckenstein Gruen G, Thimm F, Czirfus A, Matyas S, Frey M. Experimental vasoprotection by calcium antagonist against calcium-mediated arteriosclerotic alteration. J Cardiovasc Pharmacol 1994;24(suppl 2):75-84.
46. Lichtlen PR, Hugenholz PG, Raffenbeul W. Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 1990;335:1109-1113.
47. Ting HH, Timimi FK, Boles KS, et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin dependent Diabetes mellitus. J Clin Invest 1996;97:22-28.
48. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6-9.
49. Levine GN, Frei B, Koulouris SN, et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107-1113.
50. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997;96:1513-1519.
51. Grunfeld S, Hamilton CA, Mesaros S, et al. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995;26:854-857.